These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7669193)

  • 1. Improvement of dissolution characteristics of psoralen by cyclodextrins complexation.
    Vincieri FF; Mazzi G; Mulinacci N; Bambagiotti-Alberti M; Dall' Acqua F; Vedaldi D
    Farmaco; 1995; 50(7-8):543-7. PubMed ID: 7669193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
    Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
    J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
    Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
    J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
    Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
    Zhou Q; Wei X; Dou W; Chou G; Wang Z
    Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical properties of the complexes formed between heptakis(2,6-di-O-methyl)-beta-cyclodextrin, beta-cyclodextrin, and chlorambucil.
    Green AR; Miller ES; Guillory JK
    J Pharm Sci; 1991 Feb; 80(2):186-9. PubMed ID: 2051328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solving the Delivery Problems of Triclabendazole Using Cyclodextrins.
    Real D; Leonardi D; Williams RO; Repka MA; Salomon CJ
    AAPS PharmSciTech; 2018 Jul; 19(5):2311-2321. PubMed ID: 29845501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
    Rawat S; Jain SK
    Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
    Bayomi MA; Abanumay KA; Al-Angary AA
    Int J Pharm; 2002 Aug; 243(1-2):107-17. PubMed ID: 12176299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
    Mennini N; Bragagni M; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.
    Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS
    Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aging on the dissolution stability of glibenclamide/beta-cyclodextrin complex.
    Babu RJ; Pandit JK
    Drug Dev Ind Pharm; 1999 Nov; 25(11):1215-9. PubMed ID: 10596361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M; Sheha M
    Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of phenindione-beta-cyclodextrin inclusion complex.
    Tous SS; el-Sayed AM; el-Harras SA; Jun HW
    Pharmazie; 1992 May; 47(5):365-8. PubMed ID: 1409827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 1. Allopurinol.
    Ammar HO; el-Nahhas SA
    Pharmazie; 1995 Jan; 50(1):49-51. PubMed ID: 7886125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization and interaction of sulindac with beta-cyclodextrin in the solid state and in aqueous solution.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 1998 Mar; 24(3):301-6. PubMed ID: 9876589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S; Ding Y; Yao Y
    Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
    Wang L; Li S; Tang P; Yan J; Xu K; Li H
    Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.